Combined Effects of Novel Exercise and Stretching Exercise in Pregnant Females With Restless Leg Syndrome
NCT07921043, Not applicable, Completed, Riphah International University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Combined Effects of Novel Exercise and Stretching Exercise in Pregnant Females With Restless Leg Syndrome | ClinicalTrials.gov |
| NCT number | NCT07921043 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 44 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Riphah International University | ClinicalTrials.gov |
| Conditions | Restless Leg Syndrome | ClinicalTrials.gov |
| Interventions | stretching and novel exercises, novel exercises | ClinicalTrials.gov |
| First posted | 2026-11-06 | ClinicalTrials.gov |
| Last updated | 2026-11-06 | ClinicalTrials.gov |
Registered outcomes 4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | NUMERIC PAIN RATING SCALE | 6 weeks | This tool is used to measure the pain intensity in individuals. It has eleven-point numeric scale ranges from zero to ten. If zero is no pain, then ten is severe pain. It has four levels to assess the pain quality: 0 is considered as no pain, one to 3 is considered as minor pain, four to six is moderate pain, and seven to 10 is considered as severe pain | ClinicalTrials.gov |
| Secondary | QUALITY OF LIFE SCALE -SHORT FORM-12 | 6 weeks | SF-12 has 12 different items composed of eight separate headings consisting of subdivisions such as limitations related to physical restrictions, physical performance, ache vitality, emotional issues difficulty, social performance and mental wellness. It has two scores: the physical component summary score (PCS12) and the mental component summary score (MCS12. include general health physical functioning role physical and pain. | ClinicalTrials.gov |
| Secondary | GRONINGEN SLEEP QUALITY SCALE | 6 weeks | The Participant sleep routines and general quality of sleep are evaluated by using this measure. It has fifteen items with true or false values. All true things received one point, with the expectation of items eight, ten,\& twelve which had scores that were inverted .This scale scoring method is scores ranges from zero to fourteen 14 with the first question not being part of final value. It has three categories were created based on the total value normal refreshing sleep (score 0 to 2), slightly disturbed sleep" (value 3-9), \& poor quality of Sleep (10 to 14) significance | ClinicalTrials.gov |
| Secondary | RESTLESS LEG SYNDROME RATING SCALE | 6 weeks | It is a gold standard Scale. Each have ten questions on the test has a grade ranging from 0 to 4. The last five questions evaluate how affects the RLS on daily living activities or quality of life, while the first five questions should concentrate on the intensity of symptoms. The severity of disease is reflected in the total score. 40 are the highest possible score. Mild (1-10), moderate (11-20), severe (21-30), and extremely severe (31-40) are the total RLS severity scores significance | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)